Monascin and ankaflavin have more anti-atherosclerosis effect and less side effect involving increasing creatinine phosphokinase activity than monacolin K under the same dosages

TZU-MING PAN2018-09-102018-09-102013http://www.scopus.com/inward/record.url?eid=2-s2.0-84872117762&partnerID=MN8TOARShttp://scholars.lib.ntu.edu.tw/handle/123456789/377119Monascin and ankaflavin have more anti-atherosclerosis effect and less side effect involving increasing creatinine phosphokinase activity than monacolin K under the same dosagesjournal article10.1021/jf304346r